The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing ...
A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.
High profile politicians have thrown their weight behind calls to screen at-risk men for prostate cancer, but are potential ...
Eric Morrow had a family history of prostate cancer, but because he was not yet 55, they wouldn't screen him. However, a ...
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Channing Paller discussing germline and somatic genetic ...
Managing prostate cancer still begins at your doctor's office, but today we know that when it comes to treating and preventing disease, nutrition plays a role. Research confirms an association ...